38
EVENT FORMAT
Lecture
2020
Januar y
12-2 3
Drug Delivery for combatting and preventing infectious
diseases
DESCRIPTION
Infectious diseases are on the raise and increasing challenge to human health with mortality rates predicted to soon
exceed those of cancer and other diseases. While antimicrobial resistance is increasing, the number of new anti-
biotics and even the number of companies engaging in those is decreasing. Besides the need for new targets and
molecules for anti-infective compounds, such as e.g. pathoblockers, there is also a need to deliver those across
biological barriers preventing access to the target site. Relevant barriers in this context are the body’s outer epithelia,
in particular of the gut, the skin and the lung, but also host cell membranes, the bacterial cell envelope as well as
non-cellular barriers, such as mucus and bacterial biofilm. The lecture will provide an introduction in to this exciting
field of research with focus on novel nanomedicines as innovative human cell- and tissue models as alternative to
animal testing
SPEAKER Claus-Michael Lehr
CREDITS 1
Professor at Saarland University and co-founder and head of the Drug Delivery
department at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)